These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
443 related items for PubMed ID: 26142398
1. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy. Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA. Nephrol Dial Transplant; 2015 Nov; 30(11):1862-9. PubMed ID: 26142398 [Abstract] [Full Text] [Related]
4. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China. Zhang D, Zou J, Zhang C, Zhang W, Lin F, Jiang G. Med Sci Monit; 2018 Jul 22; 24():5076-5083. PubMed ID: 30032157 [Abstract] [Full Text] [Related]
6. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years. Pourcine F, Dahan K, Mihout F, Cachanado M, Brocheriou I, Debiec H, Ronco P. PLoS One; 2017 Jul 22; 12(3):e0173201. PubMed ID: 28257452 [Abstract] [Full Text] [Related]
13. Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy. Gong Z, Yuan S, Zhu X, Wang Y, Yu F, Yang D, Xu X, Liu H, Li J, Sun L. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun 28; 45(6):693-700. PubMed ID: 32879127 [Abstract] [Full Text] [Related]
14. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy. Xiao C, Liu Y, Zhang X, Luo L, Li X, Wang T, Tian Z, Qin X, Liu J. J Clin Lab Anal; 2020 Sep 28; 34(9):e23368. PubMed ID: 32449206 [Abstract] [Full Text] [Related]
15. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy]. Tang XL, DU YY, Yu J, Ye T, Zhu H, Chen YF, Li XH. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr 28; 45(2):235-244. PubMed ID: 37157070 [Abstract] [Full Text] [Related]
16. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy. Zhang C, Zhang M, Chen D, Ren Q, Xu W, Zeng C, Qin W, Liu Z. J Clin Pathol; 2019 Oct 28; 72(10):705-711. PubMed ID: 31243053 [Abstract] [Full Text] [Related]
17. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans. Lwezaula BF, Ameh OI, Ekrikpo UE, Botha FC, Okpechi-Samuel US, Wearne N, Ronco P, Bello AK, Okpechi IG. BMC Nephrol; 2021 Jan 07; 22(1):15. PubMed ID: 33413188 [Abstract] [Full Text] [Related]
18. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain. L'Imperio V, Pieruzzi F, Sinico RA, Nebuloni M, Granata A, Smith A, Radice A, Pagni F. J Nephrol; 2018 Aug 07; 31(4):543-550. PubMed ID: 29626294 [Abstract] [Full Text] [Related]
19. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy]. Kakhsurueva PA, Kamyshova ES, Bobkova IN, Stavrovskaya EV, Rudenko TE, Andreeva EY. Ter Arkh; 2023 Aug 17; 95(6):462-467. PubMed ID: 38158964 [Abstract] [Full Text] [Related]
20. Anti-PLA2R and anti-THSD7A as Diagnostic Serological Markers of Idiopathic Membranous Nephropathy: A Single Centre Study. Fouad MA, Mahedy AW, Mansour AE, Fouad NA. Egypt J Immunol; 2020 Jun 17; 27(2):1-9. PubMed ID: 33548972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]